Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

65992 1510824253HCLSReviewUkraineNovember2017.pdf
Energy Boardroom

Valeant CEO claims Allergan investors support a buyout vote

25.06.2014 / Fierce Pharma

Valeant can't make a deal for Allergan if it doesn't get shareholder support for a special meeting. That's where it hopes to overturn Allergan's board and its poison pill defense. But if you ask Valeant CEO J. Michael Pearson, his company is well on its way toward that goal.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: